جستجوی استاد راهنمای دانشگاهی

Florian Kronenberg is a Full Professor and Head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck, Austria. He has held leadership roles since 2004 and previously directed the Department of Medical Genetics, Molecular and Clinical Pharmacology (2008–2017). His research focuses on genetic and clinical epidemiological studies, particularly on lipoprotein(a) as a major genetic risk factor for cardiovascular disease. He leads a team with the largest sample collection (40,000+ individuals) for LPA gene characterization and serves as Co-Editor of Atherosclerosis , contributing to international guidelines (K/DOQI, KDIGO, EAS). MD from University of Innsbruck Training in Medical Genetics at Gerd Utermann's lab Postdoctoral work at University of Utah His work spans over 500 publications (400+ original papers, 100+ reviews) with an H-index of 107 (Google Scholar) and 47,408+ citations. Key research areas include lipoprotein metabolism, genetic epidemiology, and the interplay of complex diseases like atherosclerosis, kidney disease, and diabetes mellitus. Recent publications emphasize Mendelian randomization, cardiovascular risk stratification, and molecular genetics of LPA variants. Scientific Awards & Honors Lifetime Achievement Award (Dr. Johannes und Hertha Tuba-Stiftung, 2021) APART Fellowship (Austrian Academy of Sciences, 1997–2000) Knoll William Harvey Prize (1999) Research awards from Austrian Stroke Foundation, Diabetes Association, and others

• Lipoprotein metabolism
• Genetic epidemiology
• Lipoprotein(a)
• +۳ مورد دیگر

Harald Pichler is an Associate Professor and Team Leader at the Institute of Biotechnology (IMBT) at Graz University of Technology. His research focuses on membrane biology, enzyme engineering, and industrial biotechnology using yeast systems like Pichia pastoris . Key projects include engineering microbial membranes for protein secretion, optimizing biocatalysts for terpenoid synthesis, and studying lipid interactions with membrane proteins. Collaborations with companies like DSM and LONZA highlight industrial applications of his work. Research interests span microbial membrane modifications, sterol biosynthesis, and metabolic engineering for producing valuable metabolites. Major contributions include developing yeast strains for high-throughput screening of terpenoids and engineering hydratases for biocatalytic applications. His team also explores protein secretion pathways and membrane protein expression in yeasts, with patent filings for key genetic targets. Current projects involve lipid raft dynamics, SARS-CoV-2 spike protein interactions with membranes, and low-cost cell culture media alternatives. Collaborations with academic partners like the University of Geneva and Wageningen University emphasize interdisciplinary approaches. Publications frequently address membrane biophysics, enzyme mechanisms, and yeast strain engineering, reflecting a blend of fundamental and applied research.

• Membrane Biology
• Industrial Biotechnology
• Enzyme Engineering
• +۴ مورد دیگر

Professor Željko Reiner, born in 1953 in Croatia, is a full professor at the School of Medicine, University of Zagreb (since 1988) and University of Rijeka (since 2012). He has served as head of the Department for Metabolic Diseases (since 2002) and previously led the Department of Internal Diseases and Institute of Pathophysiology at University Hospital Center Zagreb. His expertise spans preventive cardiology , cardiovascular risk factors , and dyslipidemias . Education : MD and PhD from University of Zagreb International Experience : Visiting scientist at Oklahoma Medical Research Center (1985-1986), University Hospital Eppendorf (1979-1980), and France. Research Focus : Professor Reiner specializes in the pathogenesis of atherosclerosis, serum lipoprotein metabolism, and pharmacotherapy strategies for cardiovascular disease prevention. His work bridges clinical endocrinology, metabolic disorders, and preventive cardiology. Grants & Leadership : He has led numerous research programs funded by Croatia’s Ministry of Science and University of Zagreb, coordinated international multicenter trials, and contributed to European Commission FP6/FP7 evaluations. Scientific Awards Full Fellow of Croatian National Academy of Sciences and Arts (2006) Former President of Croatian Academy of Medical Sciences (2004-2012) Fellow of Royal College of Physicians (FRCP), European Society of Cardiology (FESC), American College of Cardiology (FACC), and American Heart Association (FAHA) Recipients of City of Zagreb Award (2010) and Laureate Reward (2012) Multiple Croatian and foreign state honors including the Korean Gwanghwa Order and Holy See Equestrian Order of the Holy Sepulchre.

• Preventive cardiology
• Familial hypercholesterolemia
• Cardiovascular risk factors diagnosis and management
• +۴ مورد دیگر

Anna Maria Dieplinger serves as an Associate Professor at the Institute for Nursing Science and Practice at Paracelsus Medical University in Salzburg, Austria. With over 50 publications spanning from 2003 to 2024, her academic career demonstrates sustained research productivity and scholarly contribution to her fields of expertise. Her research interests span multiple critical areas of healthcare, with primary focus on Nursing Science, Cardiology, and Endourology. Dr. Dieplinger's work particularly emphasizes Geriatric Care, Quality of Life Research, and Dosimetry applications in clinical settings. Her research fingerprint reveals strong engagement with Low Density Lipoprotein Cholesterol management, ST Segment Elevation Myocardial Infarction, and Endourology procedures. Analysis of her recent publications (2023-2024) shows a clear trend toward geriatric-focused clinical research, particularly examining treatment outcomes for elderly patients with prostate conditions and cardiovascular disease. Her work bridges nursing science with urological and cardiological practice, often focusing on safety, quality of life outcomes, and specialized care models for aging populations. Dr. Dieplinger has been actively engaged as a guest speaker on healthcare topics including social services implementation in hospitals, gender-specific health promotion, and chronic pain management. Her 2023-2024 publications demonstrate continued scholarly activity across multiple high-impact medical journals.

• Nursing Science
• Cardiology
• Endourology
• +۵ مورد دیگر

Karola Vorauer-Uhl is an Associate Professor at the Institute of Biochemical Engineering, Department of Biotechnology and Food Sciences, University of Natural Resources and Life Sciences, Vienna (BOKU). She is based at Muthgasse 18, Vienna, and holds a doctorate in life sciences and biotechnology. Her work is deeply rooted in biopharmaceutical technology, particularly in liposomal drug delivery and recombinant protein production. Her research interests center on advanced bioprocess technologies. She specializes in liposomal formulations for therapeutic and vaccine delivery, with a focus on protein encapsulation and liposome-protein interactions. A key methodological expertise is bio-layer interferometry (BLI) , which she uses for real-time, label-free analysis of molecular binding. Her work also encompasses CHO cell culture processes , quality by design (QbD) , process analytical technology (PAT) , and the development of recombinant proteins like erythropoietin and HIV envelope proteins for biomedical applications. The 15 most recent publications highlight a consistent research trajectory in biopharmaceutical process development and nanoparticle-based delivery systems . Early works focused on protein purification and liposome production, while recent contributions emphasize advanced analytical methods like BLI for characterizing protein-liposome interactions and implementing QbD/PAT in mammalian cell cultures. The dominant themes are liposome technology , protein characterization , and bioprocess optimization , with applications in drug and vaccine delivery. ao.Univ.Prof. (Associate Professor), BOKU Vienna Habilitation in Biopharmaceutical Technology, 2002 Promotion (PhD) in Food and Biotechnology, 1993 Dipl.-Ing. in Food and Biotechnology, 1988 Karola Vorauer-Uhl has made significant contributions to the development of liposomal therapeutics and vaccines. Her work on GMP-compliant liposome production and novel techniques like the cross-flow injection method demonstrates a strong focus on translating research into industrial applications. She has been involved in projects related to HIV vaccine development using virosomes and the therapeutic use of liposomal superoxide dismutase. Her community service includes participation in numerous scientific conferences and workshops, particularly in the fields of bioprocessing and liposome research. She is actively engaged in academic advising, as evidenced by her supervision of university theses. Her laboratory or research group appears to focus on bioprocess engineering, with expertise in recombinant protein expression, liposome formulation, and advanced analytical characterization. Collaborations with industry partners and other research institutions, especially in the area of biopharmaceuticals, are a consistent feature of her work.

• Bioprocess Technology
• Liposomal Drug Delivery
• Bio-layer Interferometry
• +۷ مورد دیگر

Edit Irén Buzás is a Professor of Immunology and Chair of the Department of Genetics, Cell- and Immunobiology at Semmelweis University, Budapest, Hungary. She is a leading researcher in extracellular vesicles (EVs), with significant contributions to standardizing EV detection and isolation methodologies. PI of the EV Research Group at Semmelweis University Leader of the MTA-SE Immune Proteogenomics EV Research Group PI of the HCEMM-SE EV group at the Hungarian Center of Excellence Molecular Medicine (EMBL partner) Founding member and Executive Chair of Education at the International Society of Extracellular Vesicles (ISEV) Her research focuses on the cardiovascular aspects of EVs, including the interference of lipoproteins in EV experiments and the development of tools for EV standardization. She has published over 50 peer-reviewed papers and pioneered techniques like differential detergent lysis and protein-to-lipid ratio analysis. Scientific awards include the 2019 Széchenyi Prize (Hungarian Government), 1995 Carol-Nachman Prize for Rheumatology, and multiple fellowships. She has organized major ISEV conferences and serves on the ERC panel. Currently, she is establishing a Central EV Research, Service, and Reference Laboratory at Semmelweis University.

• Extracellular Vesicles
• Immunology
• Autoimmunity
• +۴ مورد دیگر

Edit Irén Buzás is a Professor of Immunology and Chair of the Department of Genetics, Cell- and Immunobiology at Semmelweis University, Budapest, Hungary. Her work focuses on extracellular vesicles (EVs), autoimmunity, and rheumatology. MD from University of Szeged (1983) PhD (1996) Her research explores EV biophysical properties, RNA patterns in EV subpopulations, and the interference of lipoproteins in EV detection. She pioneered methods like differential detergent lysis and protein-to-lipid ratios for EV standardization. Current projects involve cardiovascular aspects of EVs and establishing a Central EV Research Laboratory at Semmelweis University. She has over 50 peer-reviewed publications and leads initiatives like the MTA-SE Immune Proteogenomics EV Research Group. Her work influences international EV guidelines and training networks such as EU TRAIN-EV. 2019 Corresponding Membership of the Hungarian Academy of Sciences 2019 Széchenyi Prize 1995 Carol Nachman Price for Rheumatology Buzás is a founding member and Executive Chair of Education at the International Society of Extracellular Vesicles (ISEV), organizing key conferences and shaping global EV research standards. She serves on ERC panels and collaborates with institutions like EMBL.

• Extracellular vesicles
• Exosomes
• Apoptotic bodies
• +۷ مورد دیگر

Terho Lehtimäki is a Professor and Head of the Department of Clinical Chemistry at Tampere University's Faculty of Medicine and Health Technology. He also serves as Chief Physician at Fimlab Laboratories, a major clinical laboratory in Finland. His academic roles include being a docent in medical biochemistry and clinical chemistry, and he holds an eMBA degree. His research focuses on cardiovascular disease biomarkers, atherosclerosis, omics technologies, and genetic/epigenetic factors influencing complex traits. He leads major studies like the Tampere Vascular Study and contributes to over 35 international consortia. With 1200+ peer-reviewed publications and an H-index of 147, his work has driven discoveries in over 5000 genetic variants. Notable recognitions include membership in Academia Europaea and the University of Tampere Science Prize. Education & Career MD/PhD (1992) Docent in Medical Biochemistry (1996, University of Tampere) Docent in Clinical Chemistry (2003, University of Eastern Finland) eMBA (2013) Research Interests Cardiovascular biomarkers for risk prediction Omics-based systems biology approaches Functional genetics of complex traits Epigenetic inheritance mechanisms Multimodal cohort studies (e.g., Young Finns Study) Publications & Impact His work spans Nature, Science, and NEJM, with key contributions to understanding atherosclerosis biology, genetic risk factors, and clinical translation of omics data. Recent trends emphasize multi-omics integration and precision medicine applications. Awards & Leadership Over €15M in grant funding 3 spin-off companies Scientific leadership roles in >35 international initiatives Reviewer for 50+ journals and 15 funding agencies Teaching & Mentorship Trained over 60 PhD/MSc students, many now leading academic and clinical roles. Active in problem-based learning methodologies at Tampere University's Center of Excellence. Labs & Teams Directs the Clinical Chemistry Department's research group, collaborating closely with Fimlab Laboratories and international networks like the European Eye Consortium.

• Atherosclerosis biomarkers
• Clinical Chemistry
• Genetics
• +۷ مورد دیگر

Niels Riksen is a Full Professor in Vascular Medicine at Radboud University Medical Center (Radboudumc) since 2014 and Head of the Division of Vascular Medicine. He previously served as Acting Head of the Department of Internal Medicine (2019-2021) and held leadership roles in the National Society for Vascular Medicine (2017-2019). His academic journey began with a medical degree (2002) and a Ph.D. in Clinical Pharmacology (2007, cum laude) from Radboud University, followed by postdoctoral research at University College London (2007-2008). Research Interests focus on trained innate immunity , where he pioneered the discovery that metabolic and epigenetic reprogramming of innate immune cells drives atherosclerosis. Key contributions include identifying the NLRP3 inflammasome and mevalonate pathway as critical mediators, and demonstrating how hyperglycemia and catecholamines induce long-term immune cell activation. His work bridges basic science and clinical translation, linking trained immunity to cardiovascular disease (CVD) pathophysiology and therapeutic resistance in conditions like familial hypercholesterolemia. Scientific Impact includes over 212 publications (H-index 48), with recent articles focusing on neutrophil reprogramming and epigenetic enzyme targets ( Set7 ). Grants such as the 2023 NHLBI PPG ($1.25M) and 2018 ERA-CVD MEMORY Consortium (€870k) underscore his leadership. His invited lectures at major conferences (e.g., 2024 Japanese Circulation Society, 2022 AHA, 2022 ESC) highlight global recognition. Vascular Medicine Award (2008) Einthoven Award (2008) Excellence3 Award (2006) Current work explores pharmacological modulation of trained immunity in collaboration with the Belgian Centre for Drug Design and Discovery, aiming to develop novel therapies for CVD and metabolic disorders.

• Innate Immune Reprogramming
• Atherosclerosis Pathophysiology
• Trained Innate Immunity
• +۳ مورد دیگر

**John Schwabe** is a **Professor of Structural Biology** and **Head of the Department of Molecular and Cell Biology** at the **University of Leicester**. His career includes leadership roles in academic departments and research groups. He holds a **ScD (2014)** from the University of Cambridge, a **PhD (1991)** in Structural Biology, and a **BA (Hons) Biochemistry (1987)** from Oxford University. **Research Interests**: Focus on structural biology, regulation of gene expression, molecular mechanisms of nuclear receptors, epigenetic processes (e.g., HDAC complexes), and transcriptional repression. His work bridges structural insights with functional studies in cellular processes. **Awards**: Royal Society Wolfson Research Merit Award (2013), Wellcome Trust Senior Investigator (2013), and the Max Perutz Prize (1991). He has secured significant funding, including a £2.39M Wellcome Trust Senior Investigator Award (2014–2020). **Leadership & Grants**: Organized major conferences (e.g., EMBO Nuclear Receptors meetings), led interdisciplinary research themes, and coordinated EU-funded training networks. His lab includes ~16 researchers, emphasizing collaborative science and training. **Key Contributions**: Pioneered studies on nuclear receptor-ligand interactions, HDAC regulation, and the structural basis of transcriptional repression. His work has advanced understanding of epigenetic mechanisms in health and disease.

• Structural Biology
• Gene Regulation
• Nuclear Receptors
• +۳ مورد دیگر

Andrea De Luna is an Associate Professor at the University for Continuing Education Krems, affiliated with the Center for Regenerative Medicine. Her research focuses on regenerative medicine, cartilage tissue engineering, and the therapeutic potential of extracellular vesicles (EVs) derived from mesenchymal stem cells and blood products. She leads projects funded by the Austrian Science Fund (FWF) and regional innovation programs, investigating novel strategies for osteoarthritis treatment and cartilage regeneration. Research Interests: Stem cell biology, EV-based therapies, chondrogenesis, osteoarthritis pathophysiology, bioreactor systems for cell culture, and regenerative biomaterials. Key Projects: Principal Investigator of projects such as 'Influence of cellular pre-conditioning on the therapeutic potential of adipose-derived EVs' (FWF-funded) and '3D printing of EVs from Hoffa fat pad-derived MSCs' (2024–2028). Her publications highlight advancements in EV isolation techniques, chondroprotective effects of blood-derived products, and large-scale EV production via bioreactors. Recent work emphasizes translational applications of EVs in cartilage repair and organ-on-a-chip models for disease modeling. Dr. De Luna actively collaborates with institutions like the Vienna Center for Engineering in Medicine and presents at global conferences (e.g., OARSI World Congress). Grants and funding have supported her exploration of hyperacute serum, lyophilization techniques for therapeutics, and infra-patellar fat pad-derived stem cell applications. Her lab’s innovations aim to bridge basic science and clinical regenerative solutions for musculoskeletal disorders.

• Regenerative Medicine
• Cartilage Tissue Engineering
• Stem Cell Biology
• +۳ مورد دیگر

Christopher Tauer is a researcher at the University of Natural Resources and Life Sciences, Vienna (BOKU) , affiliated with the Department of Biotechnology and Food Science and its Institute of Bioprocess Science and Engineering and Institute of Molecular Biotechnology . His work focuses on optimizing bacterial expression systems for therapeutic proteins, genetic engineering in Escherichia coli , and synthetic biology approaches for bioprocessing. Research Highlights Developing recombinant protein production platforms in E. coli and Lactobacillus plantarum Specializing in non-canonical amino acid incorporation into antibody fragments Advancing CRISPR/Cas9 and RMCE genome editing techniques Investigating ribosome stalling and stress responses during protein production Publication Trends Recent work spans synthetic biology (2025), bioprocess optimization (2024), and microbial protein engineering (2023). Earlier contributions include foundational studies on inducible promoters in lactic acid bacteria (2016) and HIV antibody structure (1990). Teaching Contributes to biotechnology education at BOKU, offering courses on microbial systems and protein engineering.

• Molecular Biotechnology
• Bioprocess Science
• Recombinant Protein Production
• +۳ مورد دیگر

Professor Peter Lieberzeit holds a position in the Department of Physical Chemistry at the University of Vienna. His expertise spans molecularly imprinted polymers (MIPs), nanotechnology, and biosensor development with applications in medical diagnostics and environmental sustainability. Recent projects include: "Simultaneous Multiparametric Readout for Low-Cost NP Sensors" (2018–2022) "ISIS" (2014–2016) "INSTANT" (2012–2015) His research aligns with UN Sustainable Development Goals, particularly in health and environmental protection. Key research interests focus on advanced materials like MIP-based nanobodies, graphene composites, and green polymer technologies for sensor fabrication. Collaborations involve international teams working on pathogen detection, drug monitoring, and eco-friendly waste treatment solutions. Professor Lieberzeit has received notable awards including the Bernd-Rode Award 2021 (2022), Fritz Feigl Preis 2011 , and Preis für gute Lehre 2022 . These recognize contributions to both scientific innovation and educational excellence. In advising and grants, he leads interdisciplinary research teams and has secured funding for projects addressing low-cost sensor technologies and virus detection. His activities include oral presentations on MIP nanobodies and poster contributions on polymer surface characterization, emphasizing practical sensor applications and collaborations with industry partners. While no specific labs are named, his work involves developing sensor platforms integrating QCM, electrochemical methods, and microfluidics, reflecting a strong focus on applied analytical chemistry and materials engineering.

• Molecularly Imprinted Polymers
• Nanoparticle Technology
• Biosensors
• +۷ مورد دیگر

Anders Hamsten is a Professor of Cardiovascular Diseases at Karolinska Institute, where he has held academic, clinical, and leadership roles since 1987. His career includes serving as Vice-Chancellor (President) of Karolinska Institute (2013-2018), Senior Consultant in Cardiology at Karolinska University Hospital (1991-present), and leadership of the Atherosclerosis Research Unit (1987-present). He has contributed extensively to research on cardiovascular diseases, genomics, and atherosclerosis. MB, Karolinska Institutet 1975 MD, Karolinska Institutet 1978 PhD in Medicine, Karolinska Institutet 1986 His research focuses on genomics, human genetics, lipoproteins, coagulation, and atherosclerosis, integrating cardiovascular medicine with molecular mechanisms. He has led groundbreaking work in lipid metabolism and thrombosis, contributing to the understanding of inherited cardiovascular risk factors. Scientific awards include: First Prize for Best Original Article (Scandinavian Society of Atherosclerosis, 1986) Friedrich Merz Prize (University of Frankfurt, 1997) Fellow of the Royal College of Physicians (FRCP) by scientific excellence (2002) Distinguished Professor Award (Karolinska Institutet, 2010) Hamsten has supervised 7 PhD students as principal supervisor and 23 as co-supervisor, mentoring prominent researchers like Fredrik Karpe, Johan Björkegren, and Maria Sabater-Lleal. His leadership also extends to editorial roles, board memberships, and contributions to Nobel Committee activities in Physiology or Medicine (2004, 2010-2012).

• Genomics
• Human genetics
• Lipoproteins
• +۴ مورد دیگر

Clemens Röhrl serves as a Research Professor at the Center of Excellence Food Technology and Nutrition within the University of Applied Sciences Upper Austria. Holding a Privatdozent qualification with Habilitation in Medical Biochemistry (2018) and PhD in Vascular Biology (2011), his academic profile demonstrates deep expertise in lipid metabolism and nutritional biochemistry at the intersection of plant science and human health. His educational background includes: Medical Biochemistry, Habilitation (Awarded January 29, 2018) Vascular Biology, PhD (Awarded March 16, 2011) Röhrl's research focuses on the molecular mechanisms of cholesterol transporters (particularly SR-B1), HDL metabolism, and the health-promoting effects of regional plants. His work bridges fundamental biochemistry with applied nutritional science, investigating how plant extracts enhance bioavailability of fat-soluble vitamins and counteract pathological processes like foam cell formation. The fingerprint analysis of his 43 research outputs reveals concentrated expertise in lipid metabolism (49%), cholesterol pathways (60%), and high-density lipoprotein research (50%), with particular emphasis on photooxidation and electron microscopy techniques. His recent publications (2024-2025) demonstrate continued innovation in nutraceutical delivery systems, with particular focus on micellization processes for fat-soluble vitamins, bioactive components of spearmint, and elderberry compounds. These studies consistently apply high-content screening and in vitro modeling to evaluate plant-based interventions for metabolic syndrome and cardiovascular health. Röhrl actively contributes to academic service through conference organization and editorial work, having chaired the Austrian Atherosclerosis Society annual meeting in 2019 and served on the editorial board of Scientific Reports (2018-2020). His current research portfolio includes two significant projects: the active Regio-Plants initiative (2023-2027) investigating health-promoting effects of regional plants across Bavaria-Tyrol-Upper Austria, and the completed TC PhytoCluster project (2019-2020) focused on in silico screening of phytogenic compounds for metabolic syndrome applications. These projects demonstrate his commitment to translating basic research into practical applications for regional health and nutrition. Röhrl leads the Research Center Wels, which functions as an interdisciplinary hub connecting food technology, nutritional science, and biochemical research. His team employs advanced techniques including high-content screening, electron microscopy, and in vitro metabolic modeling to investigate plant-based interventions for cardiovascular and metabolic health.

• Lipid Metabolism
• Biochemistry
• Cholesterol Research
• +۴ مورد دیگر